Cenra Inc. (TWSE: 3716)
Health Care · Pharmaceuticals · TW
NT$36.70
+5.46% today · +8.3% 1Y
Cenra Inc. (TWSE: 3716) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $168.43M and employs 1,902 people.
Over the last twelve months the share price has gained 8.3%, trading between 31.55 and 37.65.
Tweenvest scores Cenra Inc. across four factors: quality 71/100, value 72/100, growth 12/100, dividend 81/100. Its strongest factor is dividend.
3716 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $168.43M
- Revenue (TTM)
- $267.15M
- P/E
- 12.19
- EPS
- 3.01
- Dividend yield
- 2.73%
- Beta (5Y)
- —
- 52-week high
- NT$37.65
- 52-week low
- NT$31.55
- Avg volume (3M)
- —
- Shares outstanding
- 146.14M
- Employees
- 1,902
- Next earnings
- —
About Cenra Inc.
China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs. It also offers nutritional supplements comprising vitamins, liver toning agents, and electrolyte and calorie preparations; antipyretic, analgesic, and anti-inflammatory medicines; digestive drugs, intestinal improvement agents, and antispasmodics; cough suppressants, antihistamines, and asthma treatment agents; BPH drugs for the urinary system; hypnotic, mental stability, and antidepressant drugs; hematology/oncology drugs; and other general preparations. In addition, the company provides over the counter drugs such as vitamins, external skin care products, cold and cough medicines, anti-inflammatory analgesics, and gastrointestinal drugs; and antibacterial and disinfection medicines. Further, it manufactures animal health products, including drugs for pigs and cattle, companion animal products, poultry drugs, and feed supplements; and offers contract manufacturing services. The company was founded in 1952 and is headquartered in Taipei, Taiwan.
- ISIN
- TW0003716007
- Founded
- 2024
- Listed since
- Jan 4, 2000
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.90 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.03 | -1.14% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.57 | -1.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.79% |
Figures last refreshed Aug 18, 2026.